EICHOR
● Not Yet Recruiting
Treatment Strategy for Patients With RA-ILD
Condition: Rheumatoid Arthritis Associated Interstitial Lung Disease · Sponsor: Chinese SLE Treatment And Research Group
About this study
This is a 52-week, multicenter, prospective, open-label, randomized controlled clinical study, comparing the efficacy and safety of tocilizumab, telitacicept, and csDMARD methotrexate in patients with RA-ILD.
This description comes directly from the study's public registry record.
Talk to the study team
Xinping Tian · +86-13691165939 · tianxp6@126.com
Shangyi Jin · +86-1367049688 · jinjinboli@sina.com
Always discuss trial participation with your own doctor first.
Locations (22)
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, Henan, China | — |
| Beijing Chao-Yang Hospital, Capital Medical University | Beijing, China | — |
| China-Japan Friendship Hospital | Beijing, China | — |
| Peking Union Medical College Hospital | Beijing, China | — |
| Xuanwu Hospital, Capital Medical University | Beijing, China | — |
| China-Japan Union Hospital of Jilin University | Changchun, China | — |
| The First Affiliated Hospital of Army Medical University (Southwest Hospital) | Chongqing, China | — |
| The Second Affiliated Hospital of Dalian Medical University | Dalian, China | — |
| Handan Central Hospital | Handan, China | — |
| The Second Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, China | — |
| The First Affiliated Hospital of Anhui Medical University | Hefei, China | — |
| Affiliated Hospital of Inner Mongolia Medical University | Hohhot, China | — |
+ 10 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07643038